Comparability of Biosimilar Filgrastim with Originator Filgrastim: Protein Characterization, Pharmacodynamics, and Pharmacokinetics

Top-down MS for rapid methionine oxidation site assignment in filgrastim

(2013) Johann Holzmann et al.   ANALYTICAL AND BIOANALYTICAL CHEMISTRY

Physicochemical and Functional Comparability Between the Proposed Biosimilar Rituximab GP2013 and Originator Rituximab

(2013) Jan Visser et al.   BIODRUGS

The Continuum of Comparability Extends to Biosimilarity: How Much Is Enough and What Clinical Data Are Necessary?

(2013) M McCamish et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

Clinical experience with Zarzio® in Europe: what have we learned?

(2013) Pere Gascón et al.   SUPPORTIVE CARE IN CANCER

A non-interventional study of biosimilar granulocyte colony-stimulating factor as prophylaxis for chemotherapy-induced neutropenia in a community oncology centre

(2012) Karl Verpoort et al.   Therapeutic Advances in Medical Oncology

Physicochemical and Biologic Comparability of a Biosimilar Granulocyte Colony-Stimulating Factor with Its Reference Product

(2010) Fritz Sörgel et al.   BIODRUGS

Development of a new G-CSF product based on biosimilarity assessment

(2009) P. Gascon et al.   ANNALS OF ONCOLOGY